Drooid Logo
Back to today’s briefing

Story perspectives

Semaglutide Use Sparks Decline in Alcohol Consumption

4/2/2025

26 3

1 of 1

Story summary
  • Semaglutide drugs, such as Ozempic, are reshaping lifestyles by curbing appetite and changing how people tolerate alcohol. Users are drinking less, raising alarms in the alcohol industry about dwindling demand. As consumers gravitate towards non-alcoholic alternatives and premium beverages, the industry must navigate this evolving landscape and respond to shifting tastes.